Torrent Pharma

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE685A01028
  • NSEID: TORNTPHARM
  • BSEID: 500420
INR
4,439.55
-8.85 (-0.2%)
BSENSE

Jun 18

BSE+NSE Vol: 3.22 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Sun Pharma.Inds.
Biocon
Laurus Labs
Divi's Lab.
Dr Reddy's Labs
Torrent Pharma
Cipla
Zydus Lifesci.
Lupin
Mankind Pharma
Aurobindo Pharma
Why is Torrent Pharmaceuticals Ltd. ?
1
High Management Efficiency with a high ROCE of 24.08%
2
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 1.01 times
3
Poor long term growth as Net Sales has grown by an annual rate of 9.72% over the last 5 years
  • PAT(Q) At Rs 409.41 cr has Fallen at -29.0% (vs previous 4Q average)
  • ROCE(HY) Lowest at 14.29%
  • OPERATING PROFIT TO INTEREST (Q) Lowest at 5.75 times
4
Stock is technically in a Bullish range
  • The technical trend has improved from Mildly Bullish on 19-May-26 and has generated 2.57% returns since then
  • Multiple factors for the stock are Bullish like MACD, Bollinger Band and DOW
5
With ROCE of 30.4, it has a Very Expensive valuation with a 14.7 Enterprise value to Capital Employed
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 43.93%, its profits have risen by 23.9% ; the PEG ratio of the company is 2.8
6
High Institutional Holdings at 25.25%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Torrent Pharma should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Torrent Pharma for you?

Low Risk, High Return

Absolute
Risk Adjusted
Volatility
Torrent Pharma
37.77%
2.02
21.71%
Sensex
-4.95%
-0.49
12.94%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
11.80%
EBIT Growth (5y)
13.49%
EBIT to Interest (avg)
8.21
Debt to EBITDA (avg)
1.53
Net Debt to Equity (avg)
1.55
Sales to Capital Employed (avg)
0.90
Tax Ratio
25.56%
Dividend Payout Ratio
59.45%
Pledged Shares
0
Institutional Holding
25.25%
ROCE (avg)
22.98%
ROE (avg)
23.24%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
68
Industry P/E
34
Price to Book Value
17.94
EV to EBIT
47.53
EV to EBITDA
35.86
EV to Capital Employed
7.65
EV to Sales
11.70
PEG Ratio
4.85
Dividend Yield
0.85%
ROCE (Latest)
16.09%
ROE (Latest)
26.24%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

9What is working for the Company
NET SALES(Q)

Highest at Rs 4,197.00 cr

PBDIT(Q)

Highest at Rs 1,356.00 cr.

-27What is not working for the Company
PAT(Q)

At Rs 409.41 cr has Fallen at -29.0% (vs previous 4Q average

ROCE(HY)

Lowest at 14.29%

OPERATING PROFIT TO INTEREST (Q)

Lowest at 5.75 times

DEBT-EQUITY RATIO(HY)

Highest at 1.79 times

DEBTORS TURNOVER RATIO(HY)

Lowest at 4.54 times

INTEREST(Q)

Highest at Rs 236.00 cr

PBT LESS OI(Q)

Lowest at Rs 612.00 cr.

EPS(Q)

Lowest at Rs 10.75

Loading Valuation Snapshot...
Here's what is working for Torrent Pharma
Net Sales - Quarterly
Highest at Rs 4,197.00 cr and Grown
each quarter in the last five quarters
MOJO Watch
Near term sales trend is very positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 1,356.00 cr. and Grown
each quarter in the last five quarters
MOJO Watch
Near term Operating Profit trend is quite positive

Operating Profit (Rs Cr)

Net Sales - Quarterly
At Rs 4,197.00 cr has Grown at 31.8% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 3,185.50 Cr
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Here's what is not working for Torrent Pharma
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 612.00 cr has Fallen at -22.3% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 787.50 Cr
MOJO Watch
Near term PBT trend is very negative

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 409.41 cr has Fallen at -29.0% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 576.87 Cr
MOJO Watch
Near term PAT trend is very negative

PAT (Rs Cr)

Interest - Quarterly
At Rs 236.00 cr has Grown at 424.44%
Quarter on Quarter (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)

Operating Profit to Interest - Quarterly
Lowest at 5.75 times
in the last five quarters
MOJO Watch
The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Interest - Quarterly
Highest at Rs 236.00 cr
in the last five quarters and Increased by 424.44 % (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)

Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs 612.00 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is negative

PBT less Other Income (Rs Cr)

Earnings per Share (EPS) - Quarterly
Lowest at Rs 10.75
in the last five quarters
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (Rs)

Debt-Equity Ratio - Half Yearly
Highest at 1.79 times
in the last five half yearly periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Debtors Turnover Ratio- Half Yearly
Lowest at 4.54 times
in the last five half yearly periods
MOJO Watch
Company's pace of settling its Debtors has slowed

Debtors Turnover Ratio